Immune Checkpoint Inhibitor Therapy in Cancer: Success versus Limitations. Biomedical Research and Therapy, [S. l.], v. 9, n. 12, p. 5455–5464, 2022. DOI: 10.15419/bmrat.v9i12.784. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/784.. Acesso em: 15 nov. 2024.